Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy.
Cristina Gil-CruzChristian Perez-ShibayamaAngelina De MartinFrancesca RonchiKatrien van der BorghtRebekka NiedererLucas OnderMechthild LütgeMario NovkovicVeronika NindlGustavo Campos RamosMarkus ArnoldiniEmma M C SlackValérie Boivin-JahnsRoland JahnsMadeleine WyssCatherine MooserBart N LambrechtMicha T MaederHans RickliLukas FlatzUrs ErikssonMarkus B GeukingKathy D McCoyBurkhard LudewigPublished in: Science (New York, N.Y.) (2020)
Myocarditis can develop into inflammatory cardiomyopathy through chronic stimulation of myosin heavy chain 6-specific T helper (TH)1 and TH17 cells. However, mechanisms governing the cardiotoxicity programming of heart-specific T cells have remained elusive. Using a mouse model of spontaneous autoimmune myocarditis, we show that progression of myocarditis to lethal heart disease depends on cardiac myosin-specific TH17 cells imprinted in the intestine by a commensal Bacteroides species peptide mimic. Both the successful prevention of lethal disease in mice by antibiotic therapy and the significantly elevated Bacteroides-specific CD4+ T cell and B cell responses observed in human myocarditis patients suggest that mimic peptides from commensal bacteria can promote inflammatory cardiomyopathy in genetically susceptible individuals. The ability to restrain cardiotoxic T cells through manipulation of the microbiome thereby transforms inflammatory cardiomyopathy into a targetable disease.
Keyphrases
- heart failure
- induced apoptosis
- oxidative stress
- mouse model
- cell cycle arrest
- end stage renal disease
- endothelial cells
- binding protein
- multiple sclerosis
- pulmonary hypertension
- left ventricular
- cell death
- regulatory t cells
- mesenchymal stem cells
- prognostic factors
- insulin resistance
- induced pluripotent stem cells
- bone marrow
- smoking cessation
- liquid chromatography